Audit of B-INTERFERON treatment: Experience in the first 100 patients within the walton centre MS service

被引：0
|
作者：
Rog, DJ [1 ]
Young, CA [1 ]
Boggild, MD [1 ]
机构：
[1] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2002年 / 73卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [41] Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit
    James, Daniel
    Verigou, Eleni-Anna
    Wilson, Andrew
    O'Nions, Jenny
    Ahmed, Syeda
    Alimam, Samah
    Sekhar, Mallika
    Lambert, Jonathan
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 113 - 113
  • [42] Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B- Cell Lymphoma: Experience from a Single UK Centre
    Radford, John
    White, Ellie
    Castro, Felipe A.
    Chaturvedi, Anshuman
    Spielewoy, Nathalie
    Gibb, Adam
    Surinach, Andy
    Linton, Kim
    Shang, Aijing
    Wenger, Michael
    BLOOD, 2019, 134
  • [43] RESULTS OF R PROTOCOL- MINICHOP IN THE TREATMENT OF PATIENTS OF ADVANCED STAGE WITH NON HODGKIN B LYMPHOMAS. EXPERIENCE IN OUR CENTRE
    Roman Carla, Martinez-Geijo
    Kennedy Kyra, Velazquez
    Jose Antonio, Garcia Vela
    Francisco Javier, Lopez Jimenez
    HAEMATOLOGICA, 2016, 101 : 224 - 224
  • [44] Endomyocardial biopsy-based treatment of patients with unexplained new-onset acute heart failure: first single-centre experience
    Palecek, T.
    Kuchynka, P.
    Simek, S.
    Schramlova, J.
    Hulinska, D.
    Vitkova, I.
    Dostalova, G.
    Magage, S.
    Havranek, S.
    Linhart, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 436 - 437
  • [45] Field treatment of acute nerve function impairment in leprosy using a standardized corticosteroid regimen - first year's experience with 100 patients
    Croft, RP
    Richardus, JH
    Smith, WCS
    LEPROSY REVIEW, 1997, 68 (04) : 316 - 325
  • [46] Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis
    Caloyeras, John P.
    Zhang, Bin
    Wang, Cheng
    Eriksson, Marianne
    Fredrikson, Sten
    Beckmann, Karola
    Knappertz, Volker
    Pohl, Christoph
    Hartung, Hans-Peter
    Shah, Dhvani
    Miller, Jeffrey D.
    Sandbrink, Rupert
    Lanius, Vivian
    Gondek, Kathleen
    Russell, Mason W.
    CLINICAL THERAPEUTICS, 2012, 34 (05) : 1132 - 1144
  • [47] Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience
    Schvarcz, R
    Ando, Y
    Sonnerborg, A
    Weiland, O
    JOURNAL OF HEPATOLOGY, 1995, 23 : 17 - 21
  • [48] Management of primary and secondary non-responders to B cell depletion therapy in systemic lupus erythematosus: Results from the first 100 patients at a single centre
    Yusof, M. Y. Md
    Shaw, D.
    El-Sherbiny, Y.
    Dass, S.
    Savic, S.
    Rawstron, A. C.
    Vital, E. M.
    Emery, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S28 - S28
  • [49] Interferon beta-1b in treatment-naive paediatric patients with relapsing-remitting MS: baseline data from the BETAPAEDIC study
    Gaertner, J.
    Brueck, W.
    Weddige, A.
    Reinhardt, K.
    Bugge, J. P.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 107 - 107
  • [50] Migratory behaviour of T lymphocytes isolated from MS patients undergoing treatment with beta-interferon (IFN-beta 1b)
    Uhm, JH
    Dooley, NP
    Stuve, O
    Francis, GS
    Duquette, P
    Antel, JP
    Yong, VW
    NEUROLOGY, 1997, 48 (03) : 5006 - 5006
12345